Angiotensin II and IGF-1 Regulate Connexin43 Expression Via ERK and p38 Signaling Pathways in Vascular Smooth Muscle Cells of Coronary Artery Bypass Conduits

Journal of Surgical Research

Volumn 142, Issue 1, 2007, Pages 137-142

  Jia, Guanghong ^a   Mitra, Amit K ^a   Cheng, Gang ^a   Gangahar, Deepak M ^b   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nebraska Heart Hospital   (United States)

Author keywords

atherosclerosis; connexins; coronary artery bypass graft; gap junctions; internal mammary artery; mitogen activated protein kinase; saphenous vein; vascular smooth muscle cells

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN II; CONNEXIN 43; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SOMATOMEDIN C;

AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAPHENOUS VEIN; VASCULAR SMOOTH MUSCLE; VEIN GRAFT DISEASE; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; AGED; ANGIOTENSIN II; CELL PROLIFERATION; CELLS, CULTURED; CONNEXIN 43; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; INSULIN-LIKE GROWTH FACTOR I; MALE; MUSCLE, SMOOTH, VASCULAR; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 34547940871     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.11.007     Document Type: Article

References (32)

1. Anstadt M.P., Franga D.L., Portik-Dobos V., et al. Native matrix metalloproteinase characteristics may influence early stenosis of venous versus arterial coronary artery bypass grafting conduits. Chest 125 (2004) 1853
2. Huang B., Dreyer T., Heidt M., et al. Insulin and local growth factor PDGF induce intimal hyperplasia in bypass graft culture models of saphenous vein and internal mammary artery. Eur J Cardiothorac Surg 21 (2002) 1002
3. Grondin C.M., Campeau L., Lesperance J., et al. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation 70 (1984) I208
4. Bjork V.O., Ivert T., and Landou C. Angiographic changes in internal mammary artery and saphenous vein grafts, two weeks, one year, and five years after coronary bypass surgery. Scand J Thorac Cardiovasc Surg 15 (1981) 23
5. Jia G., Cheng G., and Agrawal D.K. Differential effects of insulin-like growth factor-1 and atheroma-associated cytokines on cell proliferation and apoptosis in plaque smooth muscle cells of symptomatic and asymptomatic patients with carotid stenosis. Immunol Cell Biol 84 (2006) 422
6. Jia G., Cheng G., and Agrawal D.K. Autophagy of vascular smooth muscle cells in atherosclerotic lesions. Autophagy 3 (2007) 63
7. Kwak B.R., Mulhaupt F., Veillard N., et al. Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22 (2002) 225
8. Kumar N., and Gilula N.B. The gap junction communication channel. Cell 84 (1996) 381
9. Chanson M., Derouette J.P., Roth I., et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta 1711 (2005) 197
10. Teunissen B.E., Jongsma H.J., and Bierhuizen M.F. Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J 25 (2004) 1979
11. Plenz G., Ko Y.S., Yeh H.I., et al. Up-regulation of connexin43 gap junctions between neointimal smooth muscle cells. Eur J Cell Biol 83 (2004) 521
12. Nerheim P.L., Meier J.L., Vasef M.A., et al. Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol 164 (2004) 589
13. Dhume A.S., and Agrawal D.K. Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle and increased apoptosis in symptomatic carotid artery disease. J Vasc Surg 38 (2003) 155
14. Krueger K.D., Mitra A.K., DelCore M.G., et al. A comparison of stent-induced stenosis in coronary and peripheral arteries. J Clin Pathol 59 (2006) 575
15. Yan M., Liu D.L., Chua Y.L., et al. Tyrosine kinase inhibitors suppress α1-adrenoceptor mediated contraction in human radial, internal mammary arteries, and saphenous vein. Neurosci Lett 29 (2002) 333 171
16. Canham P.B., Finlay H.M., and Boughner D.R. Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels. Cardiovasc Res 34 (1997) 557
17. Wong C.W., Burger F., Pelli G., et al. Dual benefit of reduced Cx43 on atherosclerosis in LDL receptor-deficient mice. Cell Commun Adhes 10 (2003) 395
18. Deglise S., Martin D., Probst H., et al. Increased connexin43 expression in human saphenous veins in culture is associated with intimal hyperplasia. J Vasc Surg 41 (2005) 1043
19. Polacek D., Bech F., McKinsey J.F., et al. Connexin43 gene expression in the rabbit arterial wall: Effects of hypercholesterolemia, balloon injury, and their combination. J Vasc Res 34 (1997) 19
20. Chadjichristos C.E., Matter C.M., Roth I., et al. Reduced connexin43 expression limits neointima formation after balloon distension injury in hypercholesterolemic mice. Circulation 113 (2006) 2835
21. Jia G., Cheng G., Soundararajan K., et al. Insulin-like growth factor-1 receptors in atherosclerotic plaques of symptomatic and asymptomatic patients with carotid stenosis: Effect of IL-12 and IFN-gamma. Am J Physiol Heart Circ Physiol 292 (2007) H1051
22. Bokkala S., Reis H.M., Rubin E., et al. Effect of angiotensin II and ethanol on the expression of connexin43 in WB rat liver epithelial cells. Biochem J 357 (2001) 769
23. Polontchouk L., Ebelt B., Jackels M., et al. Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 16 (2002) 87
24. Wang L.H., Chen J.Z., Sun Y.L., et al. Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int J Cardiol 100 (2005) 467
25. Zhang T.Y., An J.L., Gu J.Y., et al. Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma. Ai Zheng 23 (2004) 662
26. Huang J., and Kontos C.D. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioscler Thromb Vasc Biol 22 (2002) 745
27. Gonzalez-Timon B., Gonzalez-Munoz M., Zaragoza C., et al. Native and oxidized low density lipoproteins oppositely modulate the effects of insulin-like growth factor I on VSMC. Cardiovasc Res 61 (2004) 204
28. Allen R.T., Krueger K.D., Dhume A., et al. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis 10 (2005) 525
29. Aberg N.D., Blomstrand F., Aberg M.A., et al. Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro. J Neurosci Res 74 (2003) 12
30. Lin D., Boyle D.L., and Takemoto D.J. IGF-I-induced phosphorylation of connexin43 by PKCγ: Regulation of gap junctions in rabbit lens epithelial cells. Invest Ophthalmol Vis Sci 44 (2003) 1160
31. Warn-Cramer B.J., and Lau A.F. Regulation of gap junctions by tyrosine protein kinases. Biochim Biophys Acta 1662 (2004) 81
32. Jia G., Cheng G., Gangahar D.M., et al. Insulin-like growth factor-1 and TNF-α regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells. Immunol Cell Biol 84 (2006) 448